Literature DB >> 3108831

Schistosoma mansoni: structural damage and tegumental repair after in vivo treatment with praziquantel.

M K Shaw, D A Erasmus.   

Abstract

The long-term, in vivo effects of a single, subcurative dose (200 mg/kg body weight of mouse) of praziquantel on the structure of adult Schistosoma mansoni and on the process and speed of tegumental repair are described. In both male and female worms praziquantel caused often extensive damage to the tegument, in the form of surface blebbings, swellings and lesions, and vacuolization and disruption of the subtegumental tissues. Repair of the drug-induced tegumental damage occurred slowly with partial and, more rarely, complete repair only being seen after 65 days post-treatment (p.t.), although signs of damage were still observed, particularly in male worms, at 100 days p.t. In contrast, repair of damage to the subtegumental/parenchymal tissues including the tegumental perikarya occurred relatively quickly, with the majority of worms examined appearing normal by 8-12 days p.t. The possible role(s) of the host immune response in relation to the speed of tegumental repair in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108831     DOI: 10.1017/s0031182000053920

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  18 in total

1.  Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase.

Authors:  M J Doenhoff; J Modha; J R Lambertucci
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

2.  Time course of the effect of praziquantel on Schistosoma mansoni attachment in vitro: comparison with its effects on worm length and motility.

Authors:  S P da Silva; F Noël
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

3.  Quantification of praziquantel-induced damage on the surface of adult Schistosoma mansoni worms: estimation of esterase and alkaline phosphatase activity.

Authors:  P G Fallon; C McNeice; A J Probert; M J Doenhoff
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

4.  Antischistosomal effects of Ficus carica leaves extract and/or PZQ on Schistosoma mansoni infected mice.

Authors:  Shrouk M A El-Morsy; Sayed A M El-Tantawy; Eman A El-Shabasy
Journal:  J Parasit Dis       Date:  2021-07-29

5.  Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays.

Authors:  Stephanie Howe; Dorina Zöphel; Harini Subbaraman; Clemens Unger; Jana Held; Thomas Engleitner; Wolfgang H Hoffmann; Andrea Kreidenweiss
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

6.  Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection.

Authors:  Serry A El Bialy; Amira Taman; Samar N El-Beshbishi; Basem Mansour; Mohamed El-Malky; Waleed A Bayoumi; Hassan M Essa
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

7.  Effect of levamisole on the immune response of patients with schistosomiasis after treatment with praziquantel.

Authors:  J R Snyman; de K Sommers
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

8.  Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy.

Authors:  Maha M Eissa; Samia El Bardicy; Menerva Tadros
Journal:  Parasit Vectors       Date:  2011-05-11       Impact factor: 3.876

9.  Adult somatic stem cells in the human parasite Schistosoma mansoni.

Authors:  James J Collins; Bo Wang; Bramwell G Lambrus; Marla E Tharp; Harini Iyer; Phillip A Newmark
Journal:  Nature       Date:  2013-02-20       Impact factor: 49.962

10.  Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.

Authors:  Shona Wilson; Frances M Jones; Hassan K M Fofana; Aissata Doucouré; Aly Landouré; Gachuhi Kimani; Joseph K Mwatha; Moussa Sacko; Birgitte J Vennervald; David W Dunne
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.